This inventor holds 86 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 21 EPO patents, primarily in Vascular Occlusion Devices (CPC class A61B17-12172). Top assignees: Scimed Life Systems, Inc., St. Jude Medical, Cardiology Division, Inc., Aga Medical Corporation. Active years: 1987-2025.
Inventors with similar research interests:
Location History:
- Fort Wayne, IN (US) (1987)
- Blaine, MN (US) (1990 - 2001)
- North Hills, CA (US) (2011)
- Orono, MN (US) (1994 - 2012)
- Long Lake, MN (US) (1998 - 2024)
Company Filing History:
39 out of 1,831 
18 out of 843 
6 out of 48 
Years Active: 1987-2025
Areas of Expertise:
Title: Innovations of Daniel O Adams: A Leader in Vascular Occlusion Devices
Introduction: Daniel O Adams is a prominent inventor based in Orono, Minnesota, renowned for his significant contributions to the field of medical devices. With an impressive portfolio of 82 patents, he has made substantial advancements in vascular occlusion technology, demonstrating an unwavering commitment to innovation.
Latest Patents: Among his latest inventions are the percutaneous catheter directed intravascular occlusion devices. This innovative device is designed for the improved occlusion of a passageway or cavity. One remarkable embodiment focuses on occluding the left atrial appendage, which includes a first portion equipped with a plane of occlusion positioned outside the appendage, and a second portion that features a plane of occlusion designed to be partially located within the cavity of the appendage. This advancement highlights his dedication to creating solutions that enhance patient care and medical outcomes.
Career Highlights: Throughout his career, Daniel Adams has worked with notable companies such as Scimed Life Systems, Inc. and St. Jude Medical, Cardiology Division, Inc. His tenure at these organizations has allowed him to collaborate on various groundbreaking projects that push the boundaries of current medical technology.
Collaborations: Daniel has collaborated closely with esteemed colleagues, including Richard S Kusleika and Kent D Anderson. These partnerships have enabled the exchange of ideas and expertise, resulting in the development of innovative devices that improve patient treatment options.
Conclusion: Daniel O Adams exemplifies the spirit of innovation in the medical device industry. With a robust patent portfolio and a commitment to advancing healthcare technology, he continues to inspire future generations of inventors. His work serves as a testament to the importance of creativity and collaboration in driving meaningful change in medical practices.